<DOC>
	<DOCNO>NCT02020876</DOCNO>
	<brief_summary>This clinical utility study pilot base review real de-identified randomize patient case aim evaluate Urologists ' treatment recommendation review result provide Decipher test . This pilot study primary intent help guide development design future clinical utility study Decipher</brief_summary>
	<brief_title>Decision Impact Study Measure Influence DECIPHER Treatment Recommendations</brief_title>
	<detailed_description>The primary secondary objective assess retrospectively select prostate cancer patient treat radical prostatectomy one adverse pathological feature ( APFs )</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Criteria ( Participant enrollment ) Inclusion Criteria Study participant : 1 . Practicing boardcertified urologic surgeon 2 . Performing least 40 radical prostate surgery annually Exclusion Criteria Study Participants : ( 1 ) Did meet inclusion criterion Criteria ( Case selection ) Inclusion Criteria Case File : Patient case eligible study treat radical prostatectomy one adverse pathological feature present define : Pathological Gleason score &gt; = 8 Gleason score 7 primary pattern 4 ; Pathological stage T3A ( = Extraprostatic extension ) T3B ( =Seminal vesicle invasion ) ; Positive surgical margin Gleason grade upgrade biopsy surgery Exclusion Criteria Case File : Metastatic disease ( M+ ) prior surgery Received neoadjuvant prostate cancer treatment radical prostatectomy ( radiation , hormone , chemotherapy )</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>